Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs BIOCON - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH BIOCON PROCTER & GAMBLE HEALTH/
BIOCON
 
P/E (TTM) x 34.4 19.7 174.7% View Chart
P/BV x 10.5 1.8 581.9% View Chart
Dividend Yield % 2.0 0.6 356.3%  

Financials

 PROCTER & GAMBLE HEALTH   BIOCON
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-23
BIOCON
Mar-23
PROCTER & GAMBLE HEALTH/
BIOCON
5-Yr Chart
Click to enlarge
High Rs5,366388 1,383.6%   
Low Rs3,883192 2,026.6%   
Sales per share (Unadj.) Rs740.793.1 795.9%  
Earnings per share (Unadj.) Rs138.25.4 2,581.1%  
Cash flow per share (Unadj.) Rs155.214.6 1,060.8%  
Dividends per share (Unadj.) Rs95.001.50 6,333.3%  
Avg Dividend yield %2.10.5 396.8%  
Book value per share (Unadj.) Rs447.6146.5 305.5%  
Shares outstanding (eoy) m16.601,200.60 1.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.23.1 200.6%   
Avg P/E ratio x33.554.1 61.8%  
P/CF ratio (eoy) x29.819.8 150.5%  
Price / Book Value ratio x10.32.0 522.5%  
Dividend payout %68.728.0 245.4%   
Avg Mkt Cap Rs m76,761347,814 22.1%   
No. of employees `000NANA-   
Total wages/salary Rs m2,06221,810 9.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12,296111,742 11.0%  
Other income Rs m1847,681 2.4%   
Total revenues Rs m12,480119,423 10.5%   
Gross profit Rs m3,24716,611 19.5%  
Depreciation Rs m28111,131 2.5%   
Interest Rs m84,190 0.2%   
Profit before tax Rs m3,1428,971 35.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8472,541 33.3%   
Profit after tax Rs m2,2956,430 35.7%  
Gross profit margin %26.414.9 177.6%  
Effective tax rate %27.028.3 95.2%   
Net profit margin %18.75.8 324.3%  
BALANCE SHEET DATA
Current assets Rs m11,713123,340 9.5%   
Current liabilities Rs m6,79185,107 8.0%   
Net working cap to sales %40.034.2 117.0%  
Current ratio x1.71.4 119.0%  
Inventory Days Days263129 203.7%  
Debtors Days Days343117 294.3%  
Net fixed assets Rs m10,617394,078 2.7%   
Share capital Rs m1666,003 2.8%   
"Free" reserves Rs m7,265169,926 4.3%   
Net worth Rs m7,431175,929 4.2%   
Long term debt Rs m0152,905 0.0%   
Total assets Rs m22,330517,418 4.3%  
Interest coverage x409.13.1 13,022.8%   
Debt to equity ratio x00.9 0.0%  
Sales to assets ratio x0.60.2 255.0%   
Return on assets %10.32.1 502.4%  
Return on equity %30.93.7 845.0%  
Return on capital %42.44.0 1,059.1%  
Exports to sales %03.1 0.0%   
Imports to sales %13.16.0 219.3%   
Exports (fob) Rs mNA3,467 0.0%   
Imports (cif) Rs m1,6056,654 24.1%   
Fx inflow Rs m1,4653,467 42.3%   
Fx outflow Rs m1,6056,654 24.1%   
Net fx Rs m-140-3,187 4.4%   
CASH FLOW
From Operations Rs m2,36018,525 12.7%  
From Investments Rs m-215-142,818 0.2%  
From Financial Activity Rs m-985130,487 -0.8%  
Net Cashflow Rs m1,1606,411 18.1%  

Share Holding

Indian Promoters % 0.0 40.4 -  
Foreign collaborators % 51.8 20.3 255.5%  
Indian inst/Mut Fund % 20.3 21.1 96.2%  
FIIs % 7.6 6.6 116.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 39.4 122.4%  
Shareholders   56,730 434,339 13.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Procter & Gamble Health vs Biocon

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Procter & Gamble Health vs Biocon Share Price Performance

Period Procter & Gamble Health Biocon S&P BSE HEALTHCARE
1-Day -0.69% 3.04% 1.18%
1-Month -7.59% -2.42% -0.75%
1-Year -3.15% 30.66% 61.82%
3-Year CAGR -9.16% -13.51% 18.16%
5-Year CAGR 5.72% -2.70% 19.79%

* Compound Annual Growth Rate

Here are more details on the Procter & Gamble Health share price and the Biocon share price.

Moving on to shareholding structures...

The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Biocon the stake stands at 60.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Biocon.

Finally, a word on dividends...

In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.

Biocon paid Rs 1.5, and its dividend payout ratio stood at 28.0%.

You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Biocon.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.